We could not find any results for:
Make sure your spelling is correct or try broadening your search.
hVIVO PLC 05 October 2023 hVIVO plc ("hVIVO" or the "Company") Positive results from influenza human challenge study conducted by hVIVO Pneumagen to advance antiviral...
hVIVO PLC 28 April 2023 28 April 2023 hVIVO plc ("hVIVO" or the "Company") Annual Report & Notice of AGM hVIVO plc (AIM & Euronext: HVO) , (formerly Open Orphan plc) a...
hVIVO PLC 26 April 2023 hVIVO plc ("hVIVO" or the "Company") FDA grants Breakthrough Therapy and Fast Track designations to SAB Biotherapeutics' influenza candidate Data...
hVIVO PLC 25 April 2023 hVIVO plc ("hVIVO" or the "Company") Final results Transformational year with record EBITDA underlining strong operational delivery hVIVO plc (AIM...
hVIVO PLC 19 April 2023 19 April 2023 hVIVO plc ("hVIVO" or the "Company") Notice of results hVIVO plc (AIM & Euronext: HVO) , (formerly Open Orphan plc) a rapidly growing...
hVIVO PLC 06 April 2023 The Company has received the below TR-1 from Cathal Friel. As a result of an increase in the Company's share capital Mr Friel's percentage holding has now fallen...
hVIVO PLC 03 April 2023 hVIVO plc ("hVIVO" or the "Company") Positive results from influenza human challenge study conducted by hVIVO hVIVO plc (AIM & Euronext: HVO...
hVIVO PLC 29 March 2023 hVIVO plc ("hVIVO" or the "Company") World Vaccine Congress Presentation hVIVO plc (AIM & Euronext: HVO) , (formerly Open Orphan plc) a rapidly...
hVIVO PLC 23 March 2023 hVIVO plc ("hVIVO" or the "Company") Exercise of Options hVIVO plc (AIM: HVO) (formerly Open Orphan plc), a rapidly growing specialist contract...
hVIVO PLC 16 March 2023 hVIVO plc ("hVIVO" or the "Company") Omicron human challenge model update hVIVO plc (AIM & Euronext: HVO) , (formerly Open Orphan plc) a rapidly...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions